Search - tctmd.com

Displaying 1 - 20 of 61

Sort: Relevancy | Date

The Biggest News of 2018: TCTMD’s Top 10

News Daily News

The Biggest News of 2018: TCTMD’s Top 10

December 31, 2018

Metoclopramide May Mute Morphine’s Hampering of Ticagrelor Efficacy

News Daily News

Metoclopramide May Mute Morphine’s Hampering of Ticagrelor Efficacy

November 28, 2018

Aspirin Should Play Limited Role in Primary Prevention: Review

News Daily News

Aspirin Should Play Limited Role in Primary Prevention: Review

Michael O'Riordan

November 27, 2018

Greater Need for Cooperative Care in Women’s Heart Health, Two Studies Suggest

News Conference News AHA 2018

Greater Need for Cooperative Care in Women’s Heart Health, Two Studies Suggest

Yael L. Maxwell

November 16, 2018

Ticagrelor vs Aspirin in Patients undergoing Coronary-Artery Bypass Grafting

Presentation AHA 2018

Ticagrelor vs Aspirin in Patients undergoing Coronary-Artery Bypass Grafting

Presenter: Heribert Schunkert

November 14, 2018

TiCAB: Ticagrelor No Help for Preventing Graft Failure Post-CABG

News Conference News AHA 2018

TiCAB: Ticagrelor No Help for Preventing Graft Failure Post-CABG

November 13, 2018

Very EARLY Invasive Angiography in NSTE ACS Patients Reduces Risk of Recurrent Ischemia

News Conference News AHA 2018

Very EARLY Invasive Angiography in NSTE ACS Patients Reduces Risk of Recurrent Ischemia

Michael O'Riordan

November 11, 2018

Rivaroxaban Lowers Thromboembolic Risk in HF Patients: COMMANDER HF

News Conference News AHA 2018

Rivaroxaban Lowers Thromboembolic Risk in HF Patients: COMMANDER HF

November 11, 2018

SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around

News Daily News

SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around

Michael O'Riordan

November 06, 2018

FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients

News Daily News

FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients

October 12, 2018

Silent Infarcts Have Similar Mortality Over 10 Years as Clinically Recognized MI

News Daily News

Silent Infarcts Have Similar Mortality Over 10 Years as Clinically Recognized MI

Yael L. Maxwell

October 10, 2018

Stay Away From Warfarin-Based Triple Therapy in Patients With A-fib and CAD, Study Affirms

News Daily News

Stay Away From Warfarin-Based Triple Therapy in Patients With A-fib and CAD, Study Affirms

October 03, 2018

TCTMD’s Top 10 Most Popular Stories for September 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2018

October 02, 2018

OAC-ALONE: No Clear Answer for Best Therapy Beyond 1 Year After PCI in A-fib Patients

News Conference News TCT 2018

OAC-ALONE: No Clear Answer for Best Therapy Beyond 1 Year After PCI in A-fib Patients

September 24, 2018

Managing Aspirin Allergy Before DES Placement

Presentation TCT 2018

Managing Aspirin Allergy Before DES Placement

Presenter: Dominick J. Angiolillo, Elmir Omerovic, John A. Bittl

September 23, 2018

Polymer-Free BioFreedom Stent as Safe as Orsiro, but Not as Effective

News Conference News TCT 2018

CORRECTION: Polymer-Free BioFreedom Stent Faces Off Against Orsiro

Michael O'Riordan

September 22, 2018

EXCEL Deep Dive: Repeat Revascularization, Medical Therapy, and Anemia All Impact Patient Prognosis

News Conference News TCT 2018

EXCEL Deep Dive: Repeat Revascularization, Medical Therapy, and Anemia All Impact Patient Prognosis

Michael O'Riordan

September 21, 2018

News Opinion Off Script TCT 2018

Off Script: Welcome to the 30th TCT 2018 in Sunny San Diego

September 21, 2018

Does Aspirin Have a Role in the Management of Patients Undergoing PCI?

Presentation TCT 2018

Does Aspirin Have a Role in the Management of Patients Undergoing PCI?

Presenter: Jeroen J. Bax, Stephan Windecker, Patrick W. Serruys

September 21, 2018

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

News Conference News ESC 2018

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

September 14, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.